Kuros to Begin Fibrin-PTH Clinical Trial in Spinal Fusion
Kuros Biosciences gained FDA approval for its IND application to initiate a Phase IIA clinical trial evaluating Fibrin-PTH orthobiologic in single-level TLIF to...
Sep 03, 2019,
Kuros to Begin Fibrin-PTH Clinical Trial in Spinal Fusion
NeuroStructures Partners with Pinnacle Spine on Manufacturing, Distribution
NeuroStructures entered into a collaboration whereby it will offer Pinnacle Spine's solutions for the lateral access approach for spine surgery....
Sep 03, 2019,
SI-BONE Announces New Positive Coverage for MIS SI Joint Fusion using iFuse
Wellmark Blue Cross Blue Shield established positive coverage for minimally invasive surgical sacroiliac joint fusion using SI-BONE's iFuse Implant System in...
Sep 03, 2019,
DePuy Synthes Acquiring JointPoint Navigation Assets
DePuy Synthes Products signed a definitive agreement with JointPoint to acquire its navigation software designed for use in hip replacement. ...
Sep 03, 2019,
Nexxt Spine Launches Lordotic TLIF Oblique Interbody
Nexxt Spine launched a Lordotic TLIF Oblique interbody as part of its NEXXT MATRIXX family portfolio....
Aug 29, 2019,
4WEB Receives FDA Clearance for Cervical Stand Alone System
4WEB received FDA 510(k) clearance for its Cervical Spine Truss System-Stand Alone interbody....
Aug 29, 2019,
Life Spine Expands International Sales to 30 Countries
Life Spine announced it expanded international sales to 30Â countries, including Vietnam and South America....
Aug 29, 2019,
ApiFix Gains FDA Approval for MID-C Scoliosis Treatment
ApiFix received Humanitarian Device Exemption approval to market the MID-C Minimally Invasive Deformity Correction system to treat adolescent idiopathic scoliosis....
Aug 28, 2019,
Ortho RTI Partners to Study Ortho-R Biopolymer Matrix
Ortho Regenerative Technologies entered into an agreement to evaluate a commercial product from an unnamed orthopedic company partner for use with Ortho's Ortho-R...
Aug 28, 2019,
Onkos Surgical to Distribute OsteoCrete Bone Void Filler
Onkos Surgical will market Bone Solutions' OsteoCrete® magnesium-based bone void filler under the GenVie brand through a private label agreement....
Aug 28, 2019,
Loading new posts...
No more posts
